About Us

Archives






Vaccines Derived from Patients’ Tumor Cells Are Individualizing Cancer Treatment

Posted: June 26, 2010 at 8:16 am


The first discovery of a cancer gene marker--the BRAF oncogene for melanoma and colorectal malignancies--back in 2002 changed the way many researchers thought about cancer treatment. Rather than approach the disease based on what region of the body it stemmed from, scientists began to identify cancers in terms of their genetic signatures. Researchers now recognize more than 200 kinds of cancer--all genetically unique. [More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article




Cancer - Health - Conditions and Diseases - Colorectal cancer - Management of cancer

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.